摘要 |
<p>The present invention relates to a process for the preparation of enantiopure intermediates useful in the synthesis of valuable pharmaceutically active compounds, e.g. MAOB inhibitors, and to novel intermediates of formulae (I) and (II) wherein R21, R22, R23 and R24 are as defined in the description and claims.</p> |